OPT
Price:
$3.1599
Market Cap:
$486.27M
Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema DME, as well as a first in class VEGF C/D inhibitors for treatment with VEGF A inhibitors for the trea...[Read more]
Industry
Biotechnology
IPO Date
2020-10-16
Stock Exchange
NASDAQ
Ticker
OPT
According to Opthea Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 514.42M. This represents a change of 170.93% compared to the average of 189.88M of the last 4 quarters.
The mean historical Enterprise Value of Opthea Limited over the last ten years is 539.34M. The current 514.42M Enterprise Value has changed 9.44% with respect to the historical average. Over the past ten years (40 quarters), OPT's Enterprise Value was at its highest in in the June 2016 quarter at 2.48B. The Enterprise Value was at its lowest in in the March 2009 quarter at 0.
Average
539.34M
Median
355.51M
Minimum
75.34M
Maximum
1.73B
Discovering the peaks and valleys of Opthea Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 301.48%
Maximum Annual Enterprise Value = 1.73B
Minimum Annual Increase = -79.94%
Minimum Annual Enterprise Value = 75.34M
Year | Enterprise Value | Change |
---|---|---|
2024 | 179.73M | 138.57% |
2023 | 75.34M | -69.75% |
2022 | 249.06M | 13.58% |
2021 | 219.29M | -42.72% |
2020 | 382.83M | 5.01% |
2019 | 364.57M | -20.41% |
2018 | 458.08M | -67.07% |
2017 | 1.39B | 301.48% |
2016 | 346.46M | -79.94% |
2015 | 1.73B | 175.38% |
The current Enterprise Value of Opthea Limited (OPT) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
168.04M
5-year avg
221.25M
10-year avg
539.34M
Opthea Limited’s Enterprise Value is greater than Molecular Partners AG (130.63M), greater than MediciNova, Inc. (-41974173594.00), greater than Anebulo Pharmaceuticals, Inc. (36.46M), greater than Champions Oncology, Inc. (66.07M), greater than Cyteir Therapeutics, Inc. (-20511738.00), greater than Aerovate Therapeutics, Inc. (46.23M), greater than Adagene Inc. (22.22M), greater than Acrivon Therapeutics, Inc. Common Stock (163.47M), greater than Rezolute, Inc. (276.11M), greater than AN2 Therapeutics, Inc. (6.48M), greater than Inhibrx Biosciences, Inc. (9.32M), less than Mineralys Therapeutics, Inc. (523.81M), greater than Eliem Therapeutics, Inc. (119.64M),
Company | Enterprise Value | Market cap |
---|---|---|
130.63M | $216.81M | |
-41974173594.00 | $104.47M | |
36.46M | $37.86M | |
66.07M | $61.85M | |
-20511738.00 | $108.71M | |
46.23M | $76.81M | |
22.22M | $97.11M | |
163.47M | $202.87M | |
276.11M | $284.50M | |
6.48M | $39.99M | |
9.32M | $203.82M | |
523.81M | $621.09M | |
119.64M | $342.68M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Opthea Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Opthea Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Opthea Limited's Enterprise Value?
What is the highest Enterprise Value for Opthea Limited (OPT)?
What is the 3-year average Enterprise Value for Opthea Limited (OPT)?
What is the 5-year average Enterprise Value for Opthea Limited (OPT)?
How does the current Enterprise Value for Opthea Limited (OPT) compare to its historical average?